Nestlé has acquired Vitaflo (Liverpool, UK), a global provider of clinical nutritional products, for 40 million francs ($38 million), according to a Nestlé press release sent out on Monday. The transaction allows Nestlé to enter the global market for clinical nutrition products tailor-made for people with inherited metabolic disorders. This sector is growing rapidly as improved diagnosis and screening enable increasing numbers of cases to be detected, and new advances in science demonstrate the benefits of specialised nutrition as an integral part of clinical management.
Vitaflo has approximate annual sales of CHF 40 million ($38 million) and has enjoyed double-digit growth in the order of 30% over the last 3 years. The acquisition price is not disclosed.
Vitaflo's products are developed for infants, children, and adults with genetic disorders that affect how food is processed by the body. These disorders include phenylketonuria (PKU), maple syrup urine disease (MSUD) and homocystinuria (HCU). Inborn errors of metabolism are infrequent at an estimated 1 in 2,500-50,000 births depending on the disorder but persist from birth to adulthood. They constitute a significant proportion of genetic disorders detected in newborn babies.
Vitaflo's successful business model is underpinned by its leading science, research and product development. It is well aligned with Nestlé's global commitment to develop innovative nutritional solutions with proven health benefits, and to work with health care providers and caregivers in offering foods for people with specific nutritional needs.
"We are delighted to welcome Vitaflo into our company, whose people bring with them valuable expertise and know-how in clinical nutrition,'àsays Richard Laube, CEO of Nestlé Nutrition. 'This will help us to expand our innovation potential in the area of high quality products for infants, children and adults with very specific nutritional needs,"
Original Source: Nestlé
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Mars partners with suppliers like ADM to bring regeneratively grown ingredients to pet food
November 25th 2024Mars (Franklin, TN) is collaborating with partners and suppliers like ADM, The Anderson, Inc., Riceland Foods, and Soil and Water Outcomes Fund through its Royal Canin USA and Petcare U.S. Inc. brands to provide financial incentives to farmers to implement regenerative agricultural practices.